How to Analyse Subgroups Effectively Using Data Visualisation
In this episode, Paolo and I discuss the importance of visualisation in understanding subgroups.
In this episode, Paolo and I discuss the importance of visualisation in understanding subgroups.
We touch on a number of interesting topics during the interview, including how Altmetric and Dimensions work together in uncovering this journey, but also the insights that can be gleaned from the kind of data the tools provide.Â
I learned a lot of productivity hacks from Michael Hyatt. I’ve listened a lot to his podcasts and I used some of his recommended tools to make my plans work such as the Full Focus Planner which is kind of a calendar and a to-do list together with goal setting tips and more.
There’s a lot of community charity work we can all do but there is not a lot of work where we can maximise our impact by using our specific skills as programmers, as statisticians, and as data scientists.
I learned about the concept of leadership principles from Gary Sullivan and it helped me to better understand what kind of leader I want to be.
I’ve been working on RWE most of my career and the clinical trial data for a while now. And 20 years ago, we would have never thought about merging them together but there’s a lot of opportunities if we do this.
The recent advances in analytical methods for combining evidence from RCTs and non-RCTs, and the development of new frameworks for the inclusion of RWE in HTA have provided a greater insight on how issues around RWE uncertainty can be dealt with when estimating treatment effects for new technologies.
Join our discussion today as Thomas and I talk about this.
Today, I am sharing with you the 10 reasons to submit a poster for the PSI conference
During my early years, I was overwhelmed by so many trainings, SOPs, and processes. Only after my later years, I learned what quality is really about. Gary fundamentally helped me and many others have a very different and more insightful/helpful/easy perspective on this topic.
Today, I am interviewing Dacheng Liu from Boehringer-Ingelheim and talk about the different opportunities open for data scientists in the pharmaceutical industry and answer the different interesting points below:
Data visualisation is one of my favorite topics and today, I’ll be interviewing someone who has helped me understand about data visualization for years.